GlassScriptPhysician profile
Emy M Smith
NPI 1508104886
$7,604.19
in general payments reported to CMS, 2019-2025
26 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $770 · 2022: $620 · 2023: $2,074 · 2024: $3,895 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,938 · Food and Beverage: $1,439 · Travel and Lodging: $837.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,937.50 |
| Food and Beverage | $1,439.42 |
| Travel and Lodging | $837.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $5,726.89 | 2021-2024 | |
| Intuitive Surgical, INC. | $417.14 | 2021-2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $394.13 | 2021-2023 | Tagrisso, Imfinzi |
| La Jolla Pharmaceutical Company | $144.22 | 2021-2023 | Giapreza |
| Olympus America INC. | $109.92 | 2021-2022 | |
| Arthrex, INC. | $106.45 | 2025 | |
| Shionogi INC | $94.40 | 2022 | |
| Kerecis Limited | $81.66 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $66.52 | 2021-2022 | |
| Integra Lifesciences Corporation | $53.91 | 2024 | Integra, Surgimend, Omnigraft |
| Medtronic, INC. | $48.13 | 2022-2023 | Signia |
| Novocure INC. | $45.52 | 2021 | |
| Boston Scientific Corporation | $36.22 | 2021-2023 | |
| Potrero Medical, INC. | $34.16 | 2021 | |
| Nestle Healthcare Nutrition INC. | $31.67 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $24.34 | 2023 | Kengreal, Cleviprex |
| Cook Medical LLC | $23.65 | 2021 | |
| Merck Sharp & Dohme LLC | $23.63 | 2024 | Keytruda |
| Cvrx, INC. | $22.55 | 2025 | Barostim Neo System |
| Haemonetics Corporation | $20.04 | 2025 | Teg6s Hemostasis System |
| Davol INC. | $18.30 | 2022 | |
| Molnlycke Health Care US, LLC | $18.22 | 2022 | |
| Corcym INC | $16.99 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $16.24 | 2021 | |
| Abiomed | $14.65 | 2025 | |
| Pinnacle Biologics, INC | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emy Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.